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Abstract
The objectives of this article were to fabricate pure samples of multi-walled carbon nanotubes
(MWCNTs) and to determine their toxicity in tumor cell lines. MWCNTs were dispersed in a
concentration of the surfactant T80 that was minimally toxic. Cell-type variation in toxicity to
MWCNTs was observed but was not significantly different to unexposed controls. Additionally,
we investigated increased cell killing of the pancreatic cancer cell line PANC1 when exposed to
ultrashort (nanosecond) pulsed electrical fields (nsPEF) in the presence of MWCNTs as a
potential form of cancer therapy. We hypothesized that the unique electronic properties of
MWCNTs disrupt cell function, leading to cell death, when cells are exposed to nsPEF. We
observed a 2.3-fold reduction in cell survival in cells pulsed in the presence of MWCNTs
compared to pulsed controls. This study demonstrates that ultrashort pulse electrical field
applications have enhanced killing effects when cells are previously grown in the presence of
MWCNTs, suggesting that the electrical properties of MWCNTs play a vital role in this process
and is suggestive of a synergistic interaction between these nanomaterials and electrical fields.

1. Introduction
Carbon nanotubes (CNTs) are a novel carbon allotrope that possesses structural and electronic
properties that are unique from other carbon allotropes, such as graphite, fullerene, and diamond
[1]. Based on their unique electronic, mechanical and chemical properties, nanotubes have been
used in many applications, such as advanced scanning probes [2], electron field emission sources
[3] , hydrogen storage materials [4], and building blocks of molecular electronics [5,6]. CNTs
have highly π-conjunctive and hydrophobic sidewalls consisting of sp2 carbons [7], which
enable them to interact with the biological structures within the cell level [8]. As a result, CNTs
have been used in many biochemical applications, such as enzymatic films [9], nanostructured
medical devices, such as tissue-engineered scaffolds [8] and constructs for intracellular
drug/gene delivery [10,11]. CNTs that come into contact with bacterial cells also induce damage
at the plasma membrane [12].
The use of electrical fields in biology has yielded knowledge on the responses of cellular
components to electrical fields that are dependent upon the length of exposure and electrical field
intensity. Electroporation is perhaps one of the best recognized cellular responses to electrical
fields, where electrical applications in the order of millisecond to microsecond and electrical
field intensities in the order of 1 kV/cm induce pore formation in the outer cell membrane,
allowing for the transit of xenomolecules into the cell [13]. We have recently begun
characterizing the biological effects of ultrashort (nanosecond), pulsed electrical fields (nsPEF)
on human cells. nsPEF utilizes pulses in the order of 10-300 ns with rapid rise times and
electrical field strengths up to 350 kV/cm. As the pulse duration shortens, there is a lower
incidence of electrical field interactions that modify the outer plasma membrane and a higher
incidence of electrical field interactions that modify intracellular structures [14,15]; and because
the pulse duration is short, there are no significant thermal effects. With pulses that have sharp
rise times, and durations that are short compared to the charging time of the cell membrane, the
field penetrates throughout the cell, charging internal structures, creating distinct intra-cellular
effects (Figure 1).
The recent applications of nsPEFs to human cell lines are increasing our knowledge of
the biological effects of exposed cells and include the induction of apoptosis [16], the breakdown
of lysosome membranes [17] and calcium bursts [18,19]. Cell-type specific differences in nsPEF
exposed cells have been observed and include differences in cell survival, DNA damage, and cell

cycle parameters [20] as well as membrane potential [21] and mitochondria-mediated induction
of caspase activation [16]. Cell-type specific responses to nsPEFs are well documented but not
fully understood.
The unique structural and electronic properties of multi-walled carbon nanotubes
(MWCNTs), due to their large length-to-diameter ratio and a good conductivity, make it possible
to form a three-dimensional conducting matrix within or adjacent to cancer cells that allow
electrical conductance, possibly disrupting cell function leading to cell death. Targeting
MWCNTs specifically to cancer cells and exposing the cells to high intensity electrical fields
offer a potential novel form of cancer treatment. In this study, we correlate the survivability after
treating three cancer cell lines with MWCNTs along with application of pulsed electrical fields.
Our objectives are 1) fabricate a pure sample of MWCNTs and to use these to 2) determine their
toxicity in three different tumor cell lines. As a means of utilizing the electrical properties of
MWCNTs, we present preliminary data investigating the effects of pulsed electrical fields on cell
survival when exposed in the presence of MWCNTs.
2. Materials and Methods
MWCNTs fabrication
The catalytic decomposition of methane on iron-based catalysts was used for the MWCNTs
growth [22]. The reaction took place in a quartz tube. Under an argon flow, the furnace was
heated to the reaction temperature of 950 °C. In the step of catalyst reduction (10 min.), argon
was replaced by hydrogen (1000 cm3/min.). In the growth process, methane replaced the
hydrogen flow. The reactor was then cooled to ambient temperature under argon flow. The
MWCNTs were purified by refluxing the MWCNTs in 2.0 M nitric acid for 5 h, followed by
centrifugation, filtration, and drying under vacuum at 100°C. The MWCNTs were dispersed in
ethanol for preparing specimens suitable for TEM observation. The TEM specimens were
prepared by drying droplets of the MWCNT dispersion on carbon-coated Cu grids. The high
resolution transmission electron microscopy (HRTEM) characterization was then carried out on
a JEM-2100F (JEOL, Japan) microscope at 200 kV. Powdered MWCNTs were suspended in
Millipore water containing 0.002% polyoxyethylene sorbitan monooleate (Tween 80 Sigma
P4780) surfactant to a final concentration of 250 µg/ml [23]. The CNT dispersion was sonicated
for 2x15mins in a L&R Ultrasonics PC3 water bath sonicator and left overnight at room
temperature. Agglomerates were pelleted by centrifugation at 3,000 rpm for 5 min. (Eppendorf

5810R) and the supernatant gently removed and sonicated further for 2x15 min. The solution
was centrifuged at 10,000 rpm on a desktop ultracentrifuge and the CNT suspension removed for
experiments. The purity of the MWCNT fabrication was determined by high resolution
transmission electron microscopy (TEM) and by energy dispersive spectroscopy (EDS) using an
Oxford INCAx-sight EDS detector (Concord, MA) attached to the HRTEM. Thermogravimetric
analysis (TGA) was conducted using a TA instruments Q500 thermogravimetric balance,
working in high-resolution dynamic mode in the temperature range from 25 to 800 °C. In the
TGA experiment, the sample was maintained in a flow of dry air at 60 sccm.
Cell culture
The human pancreatic cancer cell line PANC1, the human uterine carcinoma line HeLa, and a
mouse melanoma cell line B16 were grown in DMEM growth medium supplemented with 10%
fetal bovine serum, 2mM L-Glutamine, and 1% penicillin and streptomycin. Cell cultures were
grown at 37oC in a humidified incubator with 5% CO2 atmosphere.
Determination of toxicity of the surfactant T80
Concentrations of T80 from 0.002%-1% were made in growth medium and cells incubated for
72 hours in a 96 well plate. Cell viability was measured by the MTT assay following the
manufacturer’s guidelines (Roche Applied Science, Mannheim, Germany).
Determination of toxicity of MWCNTs
When cultures were approximately 75% confluent, cells were removed by trypsinization and 105
cells per 5ml were seeded into tissue culture wells. 500 µl of growth medium was added to
control flasks, 500µl of Tween 80 surfactant (0.002%) added to a second control flask and 500µl
of prepared MWCNTs (approximately 23µg/ml final concentration) added to the final flask and
the cells incubated for 48 hours. All cells were used between passages 4-8.
The rate of growth of cells can be determined by measuring increased cell number per
unit time of a given cell population, which is determined by the length of time of the cell cycle
[24]. When a cell population is exposed to potentially harmful reagents, the length of the cell
cycle increases as cells respond to and repair induced damage, resulting in a relative decrease in
cell number per unit time compared to untreated controls. To determine growth characteristics of
cells exposed to MWCNTs, and hence the potentially harmful effects of MWCNTs, changes in
relative cell number per unit time were determined for each cell line and compared to unexposed

controls. Changes in cell numbers were determined from ln(N/No)/t where No = initial cell
number, N = final cell number, and t = time in hours between No and N.
Cell viability of PANC1 cells when exposed to nsPEF
To determine the viability of PANC1 cells exposed to nsPEF in the presence of
MWCNTs, cells were pretreated with MWNT/T80, and then exposed to nsPEFs. nsPEF
applications are known to penetrate and affect internal cellular structures [25]; and due to their
electrical properties, the presence of MWCNTs may enhance the killing effects of such pulses.
Cells were removed from tissue culture flasks by trypsinization and their concentration adjusted
to 106/ml. 140 µl (1.4x105 cells) were loaded into a 1 mm width electroporation cuvette
(BioRad, CA USA ) and placed in a 300 ns pulsed electrical field applicator as described
previously [20]. Eight pulses were applied at a repetition rate of ~1 Hz and the electrical field
produced in the electroporation cuvette was approximately 50kV/cm/pulse. Trypan blue is a vital
dye that stains dead cells blue while leaving live cells clear. Following treatment, cells were
mixed with an equal volume of trypan blue and 10 µl loaded onto a hemacytometer and the
number of live (unstained) and dead (stained) cells counted. Cell viability is determined as the
number of live cells/total cell number x100%.
Statistical analysis
Statistical significance was determined by Student’s t-test, with values of p<0.05
considered significant.

3. Results and Discussion
Purity of MWCNTs
We initially examined the purity of fabricated MWCNTs by energy dispersive spectroscopy
(EDS) connected to a transmission electron microscope (TEM). The EDS spectra acquired from
bundled MWCNTs and an opening area on the TEM grid are shown in (Figure 2.). The results
indicate pure carbon nanotubes with no contamination on the surfaces (the Cu peak is from the
supporting grid and specimen holder). From the TEM analysis and the corresponding EDS, a
non-uniformly distributed small amount of Ni and Fe (in the form of nanoparticles embedded in
a very small fraction of the MWCNTs, most likely from the fabrication process) were detected.
The average weight percentages of all contaminants were less than 1%. Also, TGA analysis was
used to investigate the purity of MWCNTs. In the TGA experiment, all the carbon is assumed

converted to CO/CO2, and any metal present is converted to an oxide. With increasing T, carbon
is converted to CO/CO2 and mass or mass % (m) decreases, Figure 3a. Characteristic combustion
temperatures of various carbon phases in the soot, e.g., amorphous carbon, CNT, can be
identified by the peak positions in the derivative data (DTG), i.e., -dm/dT vs T data, Figure 3b.
The positions of the resultant peaks can be affected by the amount of residual catalyst in the
sample and the carbon allotropy (amorphous and/or nanotubes) [26-29]. Increasing metal
catalysts residue tends to shift the DTG peaks to lower temperature, i.e., the growth catalyst also
acts as an oxidation catalyst and lowers the combustion temperature. The reported oxidation
temperature of the amorphous carbon is about 350 ◦C and for carbon nanotubes is about 480 ◦C in
the presence of residual catalysts [26-29]. Figure 3 shows the TGA and DTGA results of the
MWCNTs used in this study. The single DTG peak at 480 ◦C, Figure 3b, indicates one type of
carbon present in the sample which is related to carbon nanotubes i.e. free from amorphous
carbon. The average weight percentages of the residuals, Figure 3a, were less than 2%.

Toxicity of the surfactant T80
T80 is an effective surfactant that has been used as an emulsifier and dispersing agent for
medications, however, concentrations of between 1% and 5% have been shown to cause
abnormal reproductive development when injected into rats [30]. Due to potential adverse sideeffects, the toxicity of T80 used must be considered for the dispersion of MWCNTs. To
determine a concentration of T80 that would be minimally toxic, we grew PANC1 cells in the
presence of various concentrations of T80. Figure 4 shows that concentrations >0.2% show
decreased viability. Based on these observations, we performed experiments in 0.002% T80.
Toxicity of MWCNTs
Fabricated MWCNT preparations yielded a pure sample, indicating that our observations are
unlikely to be due to contaminants. We exposed exponentially growing cells to ~23µg/ml
MWCNT for 48 hours and measured relative changes in cell numbers in exposed versus
unexposed controls. All three cell lines exposed to MWCNTs showed a deviation of recorded
cell numbers compared to controls (-8.7%, -36.9% and +25.0% for B16, PANC1 and HeLa cells,
respectively. Table 1); however, none of the differences were statistically significant between
control and MWCNT exposed cells. This suggests that MWCNTs do not appear to disrupt the
ability of the cells to progress through the cell cycle and are, therefore, not toxic under these

conditions. There was no significant difference between controls and surfactant exposed cells,
suggesting that the surfactant was not influencing observed changes in MWCNT exposed cells.
There was a significant difference between cell lines in response to MWCNT exposure. PANC1
(-36.9%) and HeLa (+25.0%) cells were significantly different from each other (p = 0.023).
There was no significant difference between B16 and PANC1 or HeLa cells. PANC1 cells
appeared to be more sensitive to MWCNTs than HeLa or B16 cells. These cell lines are all
derived from very different cancer types, and the pancreatic cancer line PANC1 may have
properties that make it intrinsically more sensitive to MWCNTs. The MWCNT may be
packaged intracellularly in PANC1 cells such that the ability to grow and proliferate is
diminished. Alternatively, the inhibitory effects may be affected by MWCNTs that are external
to the cells.
Cell viability of PANC1 cells when exposed to nsPEF
The current-carrying capacity of carbon nanotubes has been reported to be 1,000 times higher
than copper wires [31]. CNT dispersions exposed to an electrical field have 100 fold or more
decrease in their electrical resistivity, even at concentrations of 0.005wt% [32]. The electrical
field distribution of both conventional electrochemotherapy and nsPEF applications to solid
tumors is dependent upon the size and the histology of the tumor. Solid tumors are very
heterogeneous, from tumor type to tumor type, and from individual to individual. This
heterogeneity makes it difficult to predict how an electrical field application will pass through
the tumor [33, 34]; therefore, the expected biological effects may be extremely variable. The use
of CNTs to distribute electrical fields has promising potential [35]; and although MacDonald
2008 [31] has shown that electrical conductivity in fibroblast seeded hydrogels are markedly
increased, there is no information relating to increased conductivity in tumor models. To
determine that cells exposed to nsPEF in the presence of MWCNTs have increased capacity to
eliminate cancer cells, experiments were performed exposing PANC1 cells grown in the
presence of MWCNT to eight 50 kV/cm pulses of 300 ns duration. 140µl of sample was loaded
into a cuvette with two parallel plate electrodes with an electrode area large compared to the
distance between electrodes (1mm). Energy density was 75.4 J/cm3 per pulse. (Detailed in [25])
Cell viability, as measured by trypan blue uptake, was normalized against unexposed cells
(Figure 5).

Cells grown in the presence of T80 and MWCNTs showed viabilities of 94.6+/- 3.5%
and 92.9+/-5.0%, respectively, showing that these agents alone are not toxic. There was no
significant difference (p=0.24) in cell viability when PANC1 cells were exposed to eight 300 ns
pulses compared to cells pulsed in the presence of 0.002% T80 (73.6+/-6.1% and 63.9+/-10.5%
respectively). Cells grown in the presence of MWCNTs and then pulsed (31.5+/-9.8% viability)
under the same conditions showed a significant difference in viability compared to nsPEF
exposed controls in the absence (p=0.003) or presence (p=0.02) of T80. The reduction in
significance between MWCNT nsPEF exposed cells and T80 nsPEF exposed cells shows that
T80 clearly has a synergistic role in the viability of exposed cells, possibly through interaction
with the lipid cell membrane. T80 is a surfactant that is commonly used as a food additive and
has clinical applications; therefore its use in conjunction with nsPEF applications is a distinct
possibility. Thus, cells grown in the presence of MWCNTs and exposed to high-energy pulsed
electrical fields show decreased viability. These preliminary experiments agree with the
hypothesis that MWCNT may be increasing energy dissipation, reducing cell viability.
This study demonstrates that ultrashort pulse electrical field applications have enhanced
effects when cells are previously grown in the presence of MWCNTs, suggesting the electrical
properties of MWCNTs play a vital role in this process and is suggestive of a synergistic
interaction between these nanomaterials and electrical fields. The efficacy of 300nsPEF
treatment applications to small (3-4mm) B16 derived skin melanomas in mice have been
described [36], where complete remission was reported. The electric field distribution across
small tumors is less problematic than larger tumors where a greater degree of inter-tumor and
inter-individual variation exists. The use of MWCNTs in producing a more uniform electric field
across a larger tumor would aid in predicting biological and treatment outcomes. The toxicity of
MWCNTs has been the attention of much debate, with conflicting reports [23, 37]. Reports
describing invalid results with carbon nanotubes when toxicity is measured by dye-based assays,
such as the MTT assay [38], led us to use the trypan blue exclusion method, which is a stain that
is excluded in live cells but taken up by dead cells, giving them a blue appearance [39] and is
used as the basis of numerous toxicity studies. The trypan blue assay has been described to
underestimate cellular toxicity [40]; therefore, our results can be considered to be conservative
estimates and may explain the increase in cell numbers observed in HeLa cells compared to
PANC1 cells. This is the first report measuring the toxicity of MWCNTs on PANC1 cells and

shows that, although not statistically significant, there is a 40% reduction in population doubling
in these cells, suggesting a slight toxic effect. Our results showing little toxicity in HeLa cells
are in agreement with Yehia et al [41], although their results use single-walled CNTs rather than
the MWCNTs described in our experiments. MWCNTs are considered to be less toxic than
single-walled carbon nanotubes [42]. There are no reports on the toxicity of MWCNTs on B16
cells; however, the use of SWCNTs to carry small interfering RNA (siRNA) to modify dendritic
cells and, thus, be able to reduce the growth of B16 melanoma cells through immunologic
mechanisms have been described [43]. We have observed that the proportion of cells that have
doubled when grown in the presence of MWCNTs appears to be cell-type specific; with the
pancreatic cancer cell line PANC1 showing the greatest reduction compared to B16 and HeLa
cells. Since the same MWCNTs preparation was used throughout the experiments, differences in
MWCNTs preparations do not account for differences in the observed population doubling
times. It is possible that the cell lines studied here each react differently to this type of
MWCNTs, a concept that may be of importance in respect to use of MWCNTs in cancer
treatment. Interestingly, pancreatic cancer has a poor prognosis, and very few successful and
reliable treatments for this cancer type exist. We plan to perform experiments to confirm the
localization of the MWCNTs in each cell type by atomic force microscopy with Raman
spectroscopy. Applications of this technology in vivo will require the addition of functional
groups to the MWCNTs to target specific cell types. The addition of functional groups has been
described [44], however, functional groups are attached to the outer wall only which does not
interfere with the electrical properties of the inner walls. We therefore expect that the electrical
properties of functionalized MWCNTs will not be significantly diminished.
Our observations that PANC1 cells additionally are sensitive to ultrashort pulsed
electrical fields, with a further 2.3-fold reduction in cell viability compared to pulsed control
cells, is of considerable interest. A two-fold increase in apoptosis has been reported in PANC1
cells upon inhibition of selected kinases [45]. An increase in the induction of apoptosis as a
cause of reduction in cell viability is a strong possibility and warrants further investigation. The
same authors also report that chemotherapeutic agents are ineffective with pancreatic
adenocarcinoma because this cancer is resistant to apoptosis induction. Targeting of pancreatic
cancer cells with MWCNTs along with application of pulsed electrical fields may have potential
as a future treatment modality. Successful treatment of a basal cell carcinoma has recently been

reported using 12ns pulse electrical fields [46], and the use of pulse electrical fields in
electrochemotherapy has undergone clinical trials [47]. This is the first report exploiting the
electrical properties of MWCNTs in conjunction with pulse electrical fields to achieve increased
cell death.
4. Conclusions
The fabrication of a pure sample of MWCNTs is described, and preliminary data have
successfully demonstrated the feasibility of utilizing the electrical properties of carbon nanotubes
with pulsed electrical field applications to achieve synergistic cell death. Pulsed electrical field
applications are becoming increasingly common in cancer treatment, and the use of carbon
nanotubes as a biomaterial to facilitate cell death is an important addition to this field. We plan to
investigate improved electrical field distribution in solid tumors when using this biomaterial.
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Figure Legends

Figure 1 shows a schematic of charge build-up following an nsPEF application to cells.

Figure 2. A high resolution TEM image and EDS analysis of MWCNTs used in this study (scale
bar 200nm). The average diameter of MWCNTs is 15 nm.

Figure 3. TGA curves (a) and corresponding DTGA curves (b) of the carbon nanotubes used in
this study.

Figure 4. PANC 1 cell viability when cells are grown in the presence of T80 (%) in growth
medium.

Figure 5. Decreased viability of 300ns pulsed PANC 1 cells when pretreated with MWCNTs
(n=3+/- SD).

